Double-method Comparative Study in Order to Predict the Use of Co-receptors From Type 1 HIV: Phenotypic Study (Trofile ESTA) and Virologic Response to a CCR5 Antagonist in the Short Term (TROPISMVC).

Trial Profile

Double-method Comparative Study in Order to Predict the Use of Co-receptors From Type 1 HIV: Phenotypic Study (Trofile ESTA) and Virologic Response to a CCR5 Antagonist in the Short Term (TROPISMVC).

Completed
Phase of Trial: Phase II/III

Latest Information Update: 12 Mar 2014

At a glance

  • Drugs Maraviroc (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms TROPISMVC
  • Most Recent Events

    • 20 Apr 2011 Planned end date changed from 1 May 2010 to 1 Nov 2011 as reported by ClinicalTrials.gov.
    • 11 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top